These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 12188412)
21. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study. Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695 [TBL] [Abstract][Full Text] [Related]
22. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related. Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Christiaens MR; Vergote I Breast Cancer Res Treat; 2005 May; 91(1):81-7. PubMed ID: 15868434 [TBL] [Abstract][Full Text] [Related]
23. Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker. Mustać E; Zamolo G; Petković M; Dordević G; Radić J; Grgurević E; Batinac T Coll Antropol; 2008 Sep; 32(3):741-6. PubMed ID: 18982746 [TBL] [Abstract][Full Text] [Related]
24. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion]. Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853 [TBL] [Abstract][Full Text] [Related]
25. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients. Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159 [TBL] [Abstract][Full Text] [Related]
26. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
27. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors. Keshgegian AA Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical expression of hormone receptors in invasive breast carcinoma: correlation of results of H-score with pathological parameters. Thike AA; Chng MJ; Fook-Chong S; Tan PH Pathology; 2001 Feb; 33(1):21-5. PubMed ID: 11280603 [TBL] [Abstract][Full Text] [Related]
29. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related]
30. Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ. Barnes NL; Boland GP; Davenport A; Knox WF; Bundred NJ Br J Surg; 2005 Apr; 92(4):429-34. PubMed ID: 15736216 [TBL] [Abstract][Full Text] [Related]
31. Hormone receptor and HER2 status in patients with breast cancer by races in southeastern Turkey. Kuzhan A; Adli M; Eryigit Alkis H; Caglayan D J BUON; 2013; 18(3):619-22. PubMed ID: 24065473 [TBL] [Abstract][Full Text] [Related]
32. The importance of prognostic factors in premenopausal women with breast cancer. Finek J; Holubec L; Topolcan O; Elgrova L; Skalova A; Pecen L Anticancer Res; 2007; 27(4A):1893-6. PubMed ID: 17649790 [TBL] [Abstract][Full Text] [Related]
33. Steroid hormone receptor association with prognostic markers in breast carcinoma in Northern Pakistan. Sharif MA; Mamoon N; Mushtaq S; Khadim MT; Jamal S J Coll Physicians Surg Pak; 2010 Mar; 20(3):181-5. PubMed ID: 20392381 [TBL] [Abstract][Full Text] [Related]
34. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528 [TBL] [Abstract][Full Text] [Related]
35. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046 [TBL] [Abstract][Full Text] [Related]
36. Breast cancer and neoadjuvant therapy: any predictive marker? Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958 [TBL] [Abstract][Full Text] [Related]
37. Risk factors for initial lung metastasis from breast invasive ductal carcinoma in stages I-III of operable patients. Gao D; Du J; Cong L; Liu Q Jpn J Clin Oncol; 2009 Feb; 39(2):97-104. PubMed ID: 19052036 [TBL] [Abstract][Full Text] [Related]
38. The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer. Park SY; Kim KS; Lee TG; Park SS; Kim SM; Han W; Noh DY; Kim SW Am J Surg; 2009 Feb; 197(2):266-9. PubMed ID: 18614146 [TBL] [Abstract][Full Text] [Related]
39. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression. Maiorana A; Cavallari V; Bagni A; Ussia F; Maiorana MC; Fano RA Anal Cell Pathol; 1996 Aug; 11(3):199-209. PubMed ID: 8888955 [TBL] [Abstract][Full Text] [Related]
40. Assessment of results of estrogen and progesterone receptor assays performed in a community hospital. Szakacs JG; Arroyo JG; Girgenti AJ Ann Clin Lab Sci; 1986; 16(4):266-73. PubMed ID: 3740795 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]